)
Stefano Portolano
CEO
Azafaros
Stefano Portolano joined as Azafaros’ CEO in 2021. Stefano has over 20 years experience in orphan disease and specialty drugs and a strong track record in building and developing high-performing teams as well as leading commercial, market access and medical affairs efforts in both Europe and the US. Before joining Azafaros, he was Head of Europe at Ultragenyx Pharmaceuticals. Prior to that Stefano spent a decade at Celgene, ending his tenure there as Vice President, Strategy & Commercial Operations where he was responsible for strategic initiatives and driving commercial execution. He also held various senior commercial, business development and general management positions at Genzyme and Sigma-Tau. Earlier in his career, Stefano was an adjunct assistant professor of Medicine at the University of California, San Francisco (UCSF), where he authored several scientific publications on the molecular biology of autoimmunity.
Stefano received his Doctor of Medicine from Università degli Studi di Napoli ‘Federico II’ in Italy
Sessions
-
22-Jun-2026Theater 4Azafaros
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}